COVID-19 Impact on Global Antiulcerant Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: C9819360BA30EN
QYResearch

Abstracts

This report focuses on the global Antiulcerant Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antiulcerant Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Takeda Pharmaceutical
• Eisai
• Daewoong Pharmaceutical
• Allergan
• AstraZeneca plc
• Valeant
• Zydus
• Shire

Market segment by Type, the product can be split into

• Proton Pump Inhibitors
• H2 Receptor Antagonists
• Gastric Mucosal Protective Drugs
• Antibiotics
• Antacids
• Prostaglandin Agonists

Market segment by Application, split into

• Mouth Ulcers
• Stomach Ulcers
• Leg Ulcer
• Esophageal Ulcer
• Bleeding Ulcer
• Neuropathic Ulcers
• Venous Stasis Ulcers
• Arterial (Ischemic) Ulcers
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Antiulcerant Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Antiulcerant Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Antiulcerant Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antiulcerant Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Antiulcerant Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Proton Pump Inhibitors
  1.4.3 H2 Receptor Antagonists
  1.4.4 Gastric Mucosal Protective Drugs
  1.4.5 Antibiotics
  1.4.6 Antacids
  1.4.7 Prostaglandin Agonists
1.5 Market by Application
  1.5.1 Global Antiulcerant Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Mouth Ulcers
  1.5.3 Stomach Ulcers
  1.5.4 Leg Ulcer
  1.5.5 Esophageal Ulcer
  1.5.6 Bleeding Ulcer
  1.5.7 Neuropathic Ulcers
  1.5.8 Venous Stasis Ulcers
  1.5.9 Arterial (Ischemic) Ulcers
  1.5.10 Others
1.6 Coronavirus Disease 2019 (Covid-19): Antiulcerant Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Antiulcerant Drugs Industry
    1.6.1.1 Antiulcerant Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Antiulcerant Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Antiulcerant Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Antiulcerant Drugs Market Perspective (2015-2026)
2.2 Antiulcerant Drugs Growth Trends by Regions
  2.2.1 Antiulcerant Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antiulcerant Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Antiulcerant Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Antiulcerant Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Antiulcerant Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antiulcerant Drugs Players by Market Size
  3.1.1 Global Top Antiulcerant Drugs Players by Revenue (2015-2020)
  3.1.2 Global Antiulcerant Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Antiulcerant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antiulcerant Drugs Market Concentration Ratio
  3.2.1 Global Antiulcerant Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Antiulcerant Drugs Revenue in 2019
3.3 Antiulcerant Drugs Key Players Head office and Area Served
3.4 Key Players Antiulcerant Drugs Product Solution and Service
3.5 Date of Enter into Antiulcerant Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Antiulcerant Drugs Historic Market Size by Type (2015-2020)
4.2 Global Antiulcerant Drugs Forecasted Market Size by Type (2021-2026)

5 ANTIULCERANT DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Antiulcerant Drugs Market Size by Application (2015-2020)
5.2 Global Antiulcerant Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Antiulcerant Drugs Market Size (2015-2020)
6.2 Antiulcerant Drugs Key Players in North America (2019-2020)
6.3 North America Antiulcerant Drugs Market Size by Type (2015-2020)
6.4 North America Antiulcerant Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Antiulcerant Drugs Market Size (2015-2020)
7.2 Antiulcerant Drugs Key Players in Europe (2019-2020)
7.3 Europe Antiulcerant Drugs Market Size by Type (2015-2020)
7.4 Europe Antiulcerant Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Antiulcerant Drugs Market Size (2015-2020)
8.2 Antiulcerant Drugs Key Players in China (2019-2020)
8.3 China Antiulcerant Drugs Market Size by Type (2015-2020)
8.4 China Antiulcerant Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Antiulcerant Drugs Market Size (2015-2020)
9.2 Antiulcerant Drugs Key Players in Japan (2019-2020)
9.3 Japan Antiulcerant Drugs Market Size by Type (2015-2020)
9.4 Japan Antiulcerant Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Antiulcerant Drugs Market Size (2015-2020)
10.2 Antiulcerant Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antiulcerant Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Antiulcerant Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Antiulcerant Drugs Market Size (2015-2020)
11.2 Antiulcerant Drugs Key Players in India (2019-2020)
11.3 India Antiulcerant Drugs Market Size by Type (2015-2020)
11.4 India Antiulcerant Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Antiulcerant Drugs Market Size (2015-2020)
12.2 Antiulcerant Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Antiulcerant Drugs Market Size by Type (2015-2020)
12.4 Central & South America Antiulcerant Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Takeda Pharmaceutical
  13.1.1 Takeda Pharmaceutical Company Details
  13.1.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
  13.1.3 Takeda Pharmaceutical Antiulcerant Drugs Introduction
  13.1.4 Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2015-2020))
  13.1.5 Takeda Pharmaceutical Recent Development
13.2 Eisai
  13.2.1 Eisai Company Details
  13.2.2 Eisai Business Overview and Its Total Revenue
  13.2.3 Eisai Antiulcerant Drugs Introduction
  13.2.4 Eisai Revenue in Antiulcerant Drugs Business (2015-2020)
  13.2.5 Eisai Recent Development
13.3 Daewoong Pharmaceutical
  13.3.1 Daewoong Pharmaceutical Company Details
  13.3.2 Daewoong Pharmaceutical Business Overview and Its Total Revenue
  13.3.3 Daewoong Pharmaceutical Antiulcerant Drugs Introduction
  13.3.4 Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2015-2020)
  13.3.5 Daewoong Pharmaceutical Recent Development
13.4 Allergan
  13.4.1 Allergan Company Details
  13.4.2 Allergan Business Overview and Its Total Revenue
  13.4.3 Allergan Antiulcerant Drugs Introduction
  13.4.4 Allergan Revenue in Antiulcerant Drugs Business (2015-2020)
  13.4.5 Allergan Recent Development
13.5 AstraZeneca plc
  13.5.1 AstraZeneca plc Company Details
  13.5.2 AstraZeneca plc Business Overview and Its Total Revenue
  13.5.3 AstraZeneca plc Antiulcerant Drugs Introduction
  13.5.4 AstraZeneca plc Revenue in Antiulcerant Drugs Business (2015-2020)
  13.5.5 AstraZeneca plc Recent Development
13.6 Valeant
  13.6.1 Valeant Company Details
  13.6.2 Valeant Business Overview and Its Total Revenue
  13.6.3 Valeant Antiulcerant Drugs Introduction
  13.6.4 Valeant Revenue in Antiulcerant Drugs Business (2015-2020)
  13.6.5 Valeant Recent Development
13.7 Zydus
  13.7.1 Zydus Company Details
  13.7.2 Zydus Business Overview and Its Total Revenue
  13.7.3 Zydus Antiulcerant Drugs Introduction
  13.7.4 Zydus Revenue in Antiulcerant Drugs Business (2015-2020)
  13.7.5 Zydus Recent Development
13.8 Shire
  13.8.1 Shire Company Details
  13.8.2 Shire Business Overview and Its Total Revenue
  13.8.3 Shire Antiulcerant Drugs Introduction
  13.8.4 Shire Revenue in Antiulcerant Drugs Business (2015-2020)
  13.8.5 Shire Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Antiulcerant Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Antiulcerant Drugs Revenue
Table 3. Ranking of Global Top Antiulcerant Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antiulcerant Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Proton Pump Inhibitors
Table 6. Key Players of H2 Receptor Antagonists
Table 7. Key Players of Gastric Mucosal Protective Drugs
Table 8. Key Players of Antibiotics
Table 9. Key Players of Antacids
Table 10. Key Players of Prostaglandin Agonists
Table 11. COVID-19 Impact Global Market: (Four Antiulcerant Drugs Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Antiulcerant Drugs Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Antiulcerant Drugs Players to Combat Covid-19 Impact
Table 16. Global Antiulcerant Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Antiulcerant Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Antiulcerant Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Antiulcerant Drugs Market Share by Regions (2015-2020)
Table 20. Global Antiulcerant Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Antiulcerant Drugs Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Antiulcerant Drugs Market Growth Strategy
Table 26. Main Points Interviewed from Key Antiulcerant Drugs Players
Table 27. Global Antiulcerant Drugs Revenue by Players (2015-2020) (Million US$)
Table 28. Global Antiulcerant Drugs Market Share by Players (2015-2020)
Table 29. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiulcerant Drugs as of 2019)
Table 30. Global Antiulcerant Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Antiulcerant Drugs Product Solution and Service
Table 33. Date of Enter into Antiulcerant Drugs Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Antiulcerant Drugs Market Size by Type (2015-2020) (Million US$)
Table 36. Global Antiulcerant Drugs Market Size Share by Type (2015-2020)
Table 37. Global Antiulcerant Drugs Revenue Market Share by Type (2021-2026)
Table 38. Global Antiulcerant Drugs Market Size Share by Application (2015-2020)
Table 39. Global Antiulcerant Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. Global Antiulcerant Drugs Market Size Share by Application (2021-2026)
Table 41. North America Key Players Antiulcerant Drugs Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Antiulcerant Drugs Market Share (2019-2020)
Table 43. North America Antiulcerant Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. North America Antiulcerant Drugs Market Share by Type (2015-2020)
Table 45. North America Antiulcerant Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. North America Antiulcerant Drugs Market Share by Application (2015-2020)
Table 47. Europe Key Players Antiulcerant Drugs Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Antiulcerant Drugs Market Share (2019-2020)
Table 49. Europe Antiulcerant Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Antiulcerant Drugs Market Share by Type (2015-2020)
Table 51. Europe Antiulcerant Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Antiulcerant Drugs Market Share by Application (2015-2020)
Table 53. China Key Players Antiulcerant Drugs Revenue (2019-2020) (Million US$)
Table 54. China Key Players Antiulcerant Drugs Market Share (2019-2020)
Table 55. China Antiulcerant Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. China Antiulcerant Drugs Market Share by Type (2015-2020)
Table 57. China Antiulcerant Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. China Antiulcerant Drugs Market Share by Application (2015-2020)
Table 59. Japan Key Players Antiulcerant Drugs Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Antiulcerant Drugs Market Share (2019-2020)
Table 61. Japan Antiulcerant Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Antiulcerant Drugs Market Share by Type (2015-2020)
Table 63. Japan Antiulcerant Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Antiulcerant Drugs Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Antiulcerant Drugs Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Antiulcerant Drugs Market Share (2019-2020)
Table 67. Southeast Asia Antiulcerant Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Antiulcerant Drugs Market Share by Type (2015-2020)
Table 69. Southeast Asia Antiulcerant Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Antiulcerant Drugs Market Share by Application (2015-2020)
Table 71. India Key Players Antiulcerant Drugs Revenue (2019-2020) (Million US$)
Table 72. India Key Players Antiulcerant Drugs Market Share (2019-2020)
Table 73. India Antiulcerant Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. India Antiulcerant Drugs Market Share by Type (2015-2020)
Table 75. India Antiulcerant Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. India Antiulcerant Drugs Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Antiulcerant Drugs Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Antiulcerant Drugs Market Share (2019-2020)
Table 79. Central & South America Antiulcerant Drugs Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Antiulcerant Drugs Market Share by Type (2015-2020)
Table 81. Central & South America Antiulcerant Drugs Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Antiulcerant Drugs Market Share by Application (2015-2020)
Table 83. Takeda Pharmaceutical Company Details
Table 84. Takeda Pharmaceutical Business Overview
Table 85. Takeda Pharmaceutical Product
Table 86. Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2015-2020) (Million US$)
Table 87. Takeda Pharmaceutical Recent Development
Table 88. Eisai Company Details
Table 89. Eisai Business Overview
Table 90. Eisai Product
Table 91. Eisai Revenue in Antiulcerant Drugs Business (2015-2020) (Million US$)
Table 92. Eisai Recent Development
Table 93. Daewoong Pharmaceutical Company Details
Table 94. Daewoong Pharmaceutical Business Overview
Table 95. Daewoong Pharmaceutical Product
Table 96. Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2015-2020) (Million US$)
Table 97. Daewoong Pharmaceutical Recent Development
Table 98. Allergan Company Details
Table 99. Allergan Business Overview
Table 100. Allergan Product
Table 101. Allergan Revenue in Antiulcerant Drugs Business (2015-2020) (Million US$)
Table 102. Allergan Recent Development
Table 103. AstraZeneca plc Company Details
Table 104. AstraZeneca plc Business Overview
Table 105. AstraZeneca plc Product
Table 106. AstraZeneca plc Revenue in Antiulcerant Drugs Business (2015-2020) (Million US$)
Table 107. AstraZeneca plc Recent Development
Table 108. Valeant Company Details
Table 109. Valeant Business Overview
Table 110. Valeant Product
Table 111. Valeant Revenue in Antiulcerant Drugs Business (2015-2020) (Million US$)
Table 112. Valeant Recent Development
Table 113. Zydus Company Details
Table 114. Zydus Business Overview
Table 115. Zydus Product
Table 116. Zydus Revenue in Antiulcerant Drugs Business (2015-2020) (Million US$)
Table 117. Zydus Recent Development
Table 118. Shire Business Overview
Table 119. Shire Product
Table 120. Shire Company Details
Table 121. Shire Revenue in Antiulcerant Drugs Business (2015-2020) (Million US$)
Table 122. Shire Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Antiulcerant Drugs Market Share by Type: 2020 VS 2026
Figure 2. Proton Pump Inhibitors Features
Figure 3. H2 Receptor Antagonists Features
Figure 4. Gastric Mucosal Protective Drugs Features
Figure 5. Antibiotics Features
Figure 6. Antacids Features
Figure 7. Prostaglandin Agonists Features
Figure 8. Global Antiulcerant Drugs Market Share by Application: 2020 VS 2026
Figure 9. Mouth Ulcers Case Studies
Figure 10. Stomach Ulcers Case Studies
Figure 11. Leg Ulcer Case Studies
Figure 12. Esophageal Ulcer Case Studies
Figure 13. Bleeding Ulcer Case Studies
Figure 14. Neuropathic Ulcers Case Studies
Figure 15. Venous Stasis Ulcers Case Studies
Figure 16. Arterial (Ischemic) Ulcers Case Studies
Figure 17. Others Case Studies
Figure 18. Antiulcerant Drugs Report Years Considered
Figure 19. Global Antiulcerant Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 20. Global Antiulcerant Drugs Market Share by Regions: 2020 VS 2026
Figure 21. Global Antiulcerant Drugs Market Share by Regions (2021-2026)
Figure 22. Porter's Five Forces Analysis
Figure 23. Global Antiulcerant Drugs Market Share by Players in 2019
Figure 24. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiulcerant Drugs as of 2019
Figure 25. The Top 10 and 5 Players Market Share by Antiulcerant Drugs Revenue in 2019
Figure 26. North America Antiulcerant Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Europe Antiulcerant Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. China Antiulcerant Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Japan Antiulcerant Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Southeast Asia Antiulcerant Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. India Antiulcerant Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Central & South America Antiulcerant Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 33. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Takeda Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2015-2020)
Figure 35. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Eisai Revenue Growth Rate in Antiulcerant Drugs Business (2015-2020)
Figure 37. Daewoong Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Daewoong Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2015-2020)
Figure 39. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Allergan Revenue Growth Rate in Antiulcerant Drugs Business (2015-2020)
Figure 41. AstraZeneca plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. AstraZeneca plc Revenue Growth Rate in Antiulcerant Drugs Business (2015-2020)
Figure 43. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Valeant Revenue Growth Rate in Antiulcerant Drugs Business (2015-2020)
Figure 45. Zydus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Zydus Revenue Growth Rate in Antiulcerant Drugs Business (2015-2020)
Figure 47. Shire Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Shire Revenue Growth Rate in Antiulcerant Drugs Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed